Astera Labs (NASDAQ:ALAB) Stock Price Up 11.5% – Time to Buy?

Shares of Astera Labs, Inc. (NASDAQ:ALAB) shot up 11.5% during mid-day trading on Friday . The company traded as high as $160.23 and last traded at $162.6340. 2,773,613 shares were traded during mid-day trading, a decline of 48% from the average session volume of 5,365,280 shares. The stock had previously closed at $145.88.

Analysts Set New Price Targets

A number of analysts have issued reports on ALAB shares. Northland Securities lifted their price target on Astera Labs from $175.00 to $195.00 and gave the stock an “outperform” rating in a report on Tuesday, December 9th. Cowen reaffirmed a “hold” rating on shares of Astera Labs in a report on Wednesday, November 5th. BNP Paribas began coverage on shares of Astera Labs in a research note on Thursday, November 20th. They issued an “outperform” rating on the stock. Wall Street Zen downgraded shares of Astera Labs from a “buy” rating to a “hold” rating in a research report on Tuesday, November 11th. Finally, Zacks Research downgraded shares of Astera Labs from a “strong-buy” rating to a “hold” rating in a research report on Monday, October 6th. One research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and eight have given a Hold rating to the company’s stock. According to MarketBeat.com, Astera Labs has a consensus rating of “Moderate Buy” and a consensus target price of $188.17.

Astera Labs Price Performance

The company has a fifty day moving average price of $160.56 and a 200 day moving average price of $154.57. The company has a market capitalization of $27.81 billion, a P/E ratio of 148.36, a price-to-earnings-growth ratio of 2.61 and a beta of 1.51.

Astera Labs (NASDAQ:ALAB) last posted its earnings results on Tuesday, November 4th. The company reported $0.49 EPS for the quarter, topping the consensus estimate of $0.39 by $0.10. The firm had revenue of $230.58 million during the quarter, compared to analysts’ expectations of $206.42 million. Astera Labs had a net margin of 27.50% and a return on equity of 13.48%. Astera Labs’s quarterly revenue was up 103.9% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.23 EPS. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. On average, equities research analysts predict that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.

Insider Buying and Selling at Astera Labs

In other news, Director Manuel Alba sold 150,000 shares of the firm’s stock in a transaction on Monday, December 1st. The stock was sold at an average price of $166.18, for a total transaction of $24,927,000.00. Following the completion of the sale, the director directly owned 1,574,498 shares of the company’s stock, valued at $261,650,077.64. This trade represents a 8.70% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, General Counsel Philip Mazzara sold 4,620 shares of the stock in a transaction on Monday, November 17th. The shares were sold at an average price of $144.69, for a total value of $668,467.80. Following the completion of the sale, the general counsel owned 147,040 shares of the company’s stock, valued at $21,275,217.60. The trade was a 3.05% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 586,936 shares of company stock valued at $89,331,140. Corporate insiders own 12.50% of the company’s stock.

Hedge Funds Weigh In On Astera Labs

Several institutional investors have recently bought and sold shares of ALAB. Fred Alger Management LLC boosted its position in Astera Labs by 13.0% in the first quarter. Fred Alger Management LLC now owns 1,560,033 shares of the company’s stock worth $93,087,000 after purchasing an additional 179,638 shares during the last quarter. Hoey Investments Inc. boosted its holdings in shares of Astera Labs by 22.4% in the 2nd quarter. Hoey Investments Inc. now owns 6,121 shares of the company’s stock worth $553,000 after buying an additional 1,121 shares during the last quarter. Sumitomo Mitsui Trust Group Inc. grew its position in Astera Labs by 21.6% during the second quarter. Sumitomo Mitsui Trust Group Inc. now owns 14,781 shares of the company’s stock valued at $1,336,000 after buying an additional 2,624 shares during the period. Wealth Effects LLC purchased a new stake in Astera Labs during the second quarter worth about $242,000. Finally, Maryland State Retirement & Pension System raised its position in Astera Labs by 37.7% in the second quarter. Maryland State Retirement & Pension System now owns 6,960 shares of the company’s stock worth $629,000 after acquiring an additional 1,906 shares during the period. 60.47% of the stock is currently owned by institutional investors.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.